16 mei 2018: Bron: Journal of Clinical Oncology

Uit een representatief Amerikaans onderzoek onder 400 oncologen blijkt dat veel Amerikaanse oncologen (80 procent) medicinale marihuana (MM) cannabis met hun patiënten bespreken en vaak ook voorschrijven (45 procent) zonder goed te weten wat de klinische effecten zouden kunnen zijn en de bijwerkingen ervan en in welke situaties wel of niet medische marihuana kan worden voorgeschreven. Slechts 30 procent van de ondervraagde oncologen gaf aan dat zij voldoende kennis hadden van medicinale marihuana / cannabis.

Klik op de titel van de studie voor het studierapport

Uit het studierapport: Medical Oncologists’ Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study

Ilana M. Braun, M.D., from the Dana-Farber Cancer Institute in Boston, and colleagues surveyed 400 medical oncologists regarding their beliefs, knowledge, and practices regarding Medical Marihuana - MM (response rate, 63 percent).

The researchers found that only 30 percent of oncologists felt sufficiently informed to make recommendations regarding MM. Far more (80 percent) discussed MM with patients, while 46 percent clinically recommended MM. Roughly two-thirds of respondents viewed MM as a helpful adjunct to standard pain management strategies; a similar proportion viewed MM as equally or more effective than standard treatments for anorexia/cachexia.

"These findings are clinically important and suggest critical gaps in research, medical education, and policy regarding MM," the authors write.

The overall response rate was 63%. Whereas only 30% of oncologists felt sufficiently informed to make recommendations regarding MM, 80% conducted discussions about MM with patients, and 46% recommended MM clinically. Sixty-seven percent viewed it as a helpful adjunct to standard pain management strategies, and 65% thought MM is equally or more effective than standard treatments for anorexia and cachexia.

Our findings identify a concerning discrepancy between oncologists’ self-reported knowledge base and their beliefs and practices regarding MM. Although 70% of oncologists do not feel equipped to make clinical recommendations regarding MM, the vast majority conduct discussions with patients about MM and nearly one-half do, in fact, recommend it clinically. A majority believes MM is useful for certain indications. These findings are clinically important and suggest critical gaps in research, medical education, and policy regarding MM.


Plaats een reactie ...

Reageer op "80 procent van amerikaanse oncologen bespreken medische marihuana met hun patienten maar de meesten doen dat zonder voldoende kennis over de effecten en bijwerkingen van medische cannabis"


Gerelateerde artikelen